◀ Back to AGTR2
AGTR2 — IL8
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Schmeisser et al., Biochem Biophys Res Commun 2004
:
AngII induced upregulation of
IL-8 and MCP-1 protein and RNA in monocytes was
inhibited by the AT1R-blocker losartan, but not by the
AT2R-blocker PD 123.319
Hochart et al., Br J Haematol 2006
(Bacterial Infections...) :
Proinflammatory cytokines tumour necrosis factor (TNF)-alpha, interleukin (IL)-8, IL-6 and IL-1beta release were subsequently measured by enzyme linked immunosorbent assay at 6 h, and nuclear translocation of the proinflammatory NF-kappaB was assessed
at 2 h. Treatment with pharmacological doses of LMWH and UFH significantly
attenuated LPS induced production of TNF-alpha,
IL-8 , IL-6 and IL-1beta as well as NF-kappaB translocation
van Meijl et al., Mol Nutr Food Res 2010
(Insulin Resistance) :
After 24 h, glutamine
inhibited IL-8 production significantly ( p < 0.05 )
at 2 , 5 and 10 mM ( to 82, 73 and 72 % of control ), whereas leucine reduced IL-8 production significantly only at 10 mM ( 66 % ) and proline at 5 and 10 mM ( 71 and 52 % )
Gao et al., Planta Med 1997
:
T2a-T2d induced human monocytes to produce interleukin-1 (IL-1),
interleukin-6 (IL-6), and tumor necrosis factor (TNF) in vitro